Measuring CAMD Technique Performance, 2. How "Druglike" Are Drugs? Implications of Random Test Set Selection Exemplified Using Druglikeness Classification Models
暂无分享,去创建一个
[1] I. Muegge. Selection criteria for drug‐like compounds , 2003, Medicinal research reviews (Print).
[2] Tudor I. Oprea,et al. Pursuing the leadlikeness concept in pharmaceutical research. , 2004, Current opinion in chemical biology.
[3] Susumu Yamanobe,et al. Development of a Method for Evaluating Drug‐Likeness and Ease of Synthesis Using a Data Set in which Compounds Are Assigned Scores Based on Chemists′ Intuition. , 2003 .
[4] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[5] Jens Sadowski,et al. Comparison of Support Vector Machine and Artificial Neural Network Systems for Drug/Nondrug Classification , 2003, J. Chem. Inf. Comput. Sci..
[6] Ajay,et al. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? , 1998, Journal of medicinal chemistry.
[7] Daniel A. Gschwend,et al. Analysis and optimization of structure-based virtual screening protocols. (3). New methods and old problems in scoring function design. , 2003, Journal of molecular graphics & modelling.
[8] Michael G. Lerner,et al. Binding MOAD (Mother Of All Databases) , 2005, Proteins.
[9] M. Wagener,et al. Potential Drugs and Nondrugs: Prediction and Identification of Important Structural Features. , 2000 .
[10] D. Rognan,et al. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. , 2000, Journal of medicinal chemistry.
[11] Paola Gramatica,et al. The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models , 2003 .
[12] Jérôme Hert,et al. Comparison of Fingerprint-Based Methods for Virtual Screening Using Multiple Bioactive Reference Structures , 2004, J. Chem. Inf. Model..
[13] Ruedi Stoop,et al. An Ontology for Pharmaceutical Ligands and Its Application for in Silico Screening and Library Design , 2002, J. Chem. Inf. Comput. Sci..
[14] M Rarey,et al. Detailed analysis of scoring functions for virtual screening. , 2001, Journal of medicinal chemistry.
[15] Stuart Murdock,et al. BioSimGrid: towards a worldwide repository for biomolecular simulations. , 2004, Organic & biomolecular chemistry.
[16] Gunnar Rätsch,et al. Classifying 'Drug-likeness' with Kernel-Based Learning Methods , 2005, J. Chem. Inf. Model..
[17] Andrew R. Leach,et al. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery , 2001, J. Chem. Inf. Comput. Sci..
[18] Andrew C. Good,et al. Measuring CAMD technique performance: A virtual screening case study in the design of validation experiments , 2004, J. Comput. Aided Mol. Des..
[19] Li Xing,et al. Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat. , 2004, Journal of medicinal chemistry.
[20] Ramamurthi Narayanan,et al. In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method. , 2005, Bioorganic & medicinal chemistry.
[21] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[22] Tudor I. Oprea,et al. WOMBAT: World of Molecular Bioactivity , 2005 .
[23] H. Kubinyi,et al. A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.
[24] D. E. Clark,et al. Prediction of intestinal absorption and blood-brain barrier penetration by computational methods. , 2001, Combinatorial chemistry & high throughput screening.
[25] Christopher A. Lipinski,et al. Capter 11 Filtering in Drug Discovery , 2005, Annual Reports in Computational Chemistry.
[26] Robin Taylor,et al. A new test set for validating predictions of protein–ligand interaction , 2002, Proteins.
[27] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[28] M. Murcko,et al. Guiding molecules towards drug-likeness. , 2002, Current opinion in drug discovery & development.
[29] Michal Vieth,et al. Dependence of molecular properties on proteomic family for marketed oral drugs. , 2006, Journal of medicinal chemistry.